ChromaDex (NASDAQ: CDXC) reported Q3 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $17.3 million versus the consensus estimate of $17.17 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.